The first successful in-patient trial of liver dialysis has been completed by researchers from UCL, the Royal Free Hospital, UCL spin-out Yaqrit and their collaborators.
May 31, 2023
0
12
In a University of California, Irvine-led study, researchers have discovered small-molecule drugs with potential clinical utility in the treatment of age-related macular degeneration (AMD), diabetic retinopathy (DR), and ...
May 8, 2023
0
64
Dr. Madhur Upadhyay and his collaborators have invented an artificial intelligence tool to assist clinicians in determining next steps for patients' orthodontic care.
Mar 22, 2023
0
6
The COVID-19 pandemic has highlighted the importance of vaccines in controlling infectious disease in sub-Saharan Africa and renewed interest in vaccine research and development across the continent.
Mar 1, 2023
0
14
Two Chinese oral anti-SARS-CoV-2 drugs, Xiannuoxin (simnotrelvir/ritonavir) and VV116 (deuremidevir hydrobromide), were conditionally approved for marketing by China's National Medical Products Administration (NMPA) in late ...
Feb 7, 2023
0
18
Some 30,000 people in the U.S. are affected by amyotrophic lateral sclerosis (ALS), also known as Lou Gehrig's disease, a neurodegenerative condition that damages cells in the brain and spinal cord necessary for movement.
Feb 4, 2023
0
132
If pharmaceutical companies shared their intellectual property rights to vaccines with the global community, millions of lives could be saved in future pandemics, according to a new paper co-authored by faculty at Binghamton ...
Jan 18, 2023
0
15
Stripping patent protection from COVID-19 treatments is a "mind-bogglingly stupid" idea, the head of a leading pharmaceutical lobby said Wednesday, warning that the move would put industry innovation at risk.
Jan 11, 2023
0
5
Technology that reliably kills airborne viruses inside buildings could prevent most cases of cold and flu and might have saved millions of lives during the COVID-19 pandemic, according to a Rutgers expert.
Nov 9, 2022
0
61
After decades of research and two previous drug development attempts, things are looking promising for a team of University of Arizona researchers working on a less toxic treatment for a specific type of breast cancer.
Oct 25, 2022
0
94
